Clinical Trial Update: A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update studies regimens of basal insulin intensified with either Symlin (pramlintide) or rapid-acting insulin in adults with Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rapid-acting insulin
• Symlin (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2009-06-04